Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

632 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of the Risk of Diabetic Retinopathy Between Sodium-Glucose Cotransporter-2 Inhibitors and Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus in Japan: A Retrospective Analysis of Real-World Data.
Koshizaka M, Tatsumi T, Kiyonaga F, Kosakai Y, Yoshinaga Y, Shintani-Tachi M. Koshizaka M, et al. Among authors: tatsumi t. Diabetes Ther. 2024 Nov;15(11):2401-2416. doi: 10.1007/s13300-024-01649-9. Epub 2024 Sep 30. Diabetes Ther. 2024. PMID: 39347896 Free PMC article.
Safety and Efficacy of Ranibizumab and Luseogliflozin Combination Therapy in Patients with Diabetic Macular Edema: Protocol for a Multicenter, Open-Label Randomized Controlled Trial.
Ishibashi R, Takatsuna Y, Koshizaka M, Tatsumi T, Takahashi S, Nagashima K, Asaumi N, Arai M, Shimada F, Tachibana K, Watanabe Y, Ishikawa K, Hoshino A, Yamamoto K, Kubota-Taniai M, Mayama T, Yamamoto S, Yokote K. Ishibashi R, et al. Among authors: tatsumi t. Diabetes Ther. 2020 Aug;11(8):1891-1905. doi: 10.1007/s13300-020-00854-6. Epub 2020 Jun 15. Diabetes Ther. 2020. PMID: 32542431 Free PMC article.
Sodium-glucose co-transporter 2 inhibitor therapy reduces the administration frequency of anti-vascular endothelial growth factor agents in patients with diabetic macular oedema with a history of anti-vascular endothelial growth factor agent use: A cohort study using the Japanese health insurance claims database.
Ishibashi R, Inaba Y, Koshizaka M, Takatsuna Y, Tatsumi T, Shiko Y, Kashiwagi Y, Maezawa Y, Kawasaki Y, Kawakami E, Yamamoto S, Yokote K. Ishibashi R, et al. Among authors: tatsumi t. Diabetes Obes Metab. 2024 Apr;26(4):1510-1518. doi: 10.1111/dom.15454. Epub 2024 Jan 19. Diabetes Obes Metab. 2024. PMID: 38240052
Sodium-glucose cotransporter 2 inhibitor therapy reduces the administration frequency of steroid injection in patients with diabetic macular edema: A cohort study using the Japanese health insurance claims database.
Ishibashi R, Koshizaka M, Takatsuna Y, Tatsumi T, Maezawa Y, Shiko Y, Inaba Y, Kawasaki Y, Kashiwagi Y, Kawakami E, Yamamoto S, Yokote K. Ishibashi R, et al. Among authors: tatsumi t. J Diabetes Investig. 2024 Sep;15(9):1231-1238. doi: 10.1111/jdi.14253. Epub 2024 Jun 14. J Diabetes Investig. 2024. PMID: 38874094 Free PMC article.
Current Treatments for Diabetic Macular Edema.
Tatsumi T. Tatsumi T. Int J Mol Sci. 2023 May 31;24(11):9591. doi: 10.3390/ijms24119591. Int J Mol Sci. 2023. PMID: 37298544 Free PMC article. Review.
Exploratory clinical trial to evaluate the efficacy and safety of transdermal electrical stimulation in patients with central retinal artery occlusion.
Miura G, Fujiwara T, Iwase T, Ozawa Y, Shiko Y, Kawasaki Y, Nizawa T, Tatsumi T, Baba T, Kurimoto T, Mori S, Nakamura M, Hanaoka H, Yamamoto S. Miura G, et al. Among authors: tatsumi t. PLoS One. 2023 Feb 24;18(2):e0282003. doi: 10.1371/journal.pone.0282003. eCollection 2023. PLoS One. 2023. PMID: 36827287 Free PMC article. Clinical Trial.
632 results